Period loss, or amenorrhea, affects approximately 3% to 4% of women of reproductive age. It can be the body’s response to an ...

The official results of the BRACELET-01 (PrECOG 0113) trial have been published in Clinical Cancer Research, detailing the ...

Introduction As the number of female athletes competing rises globally, training methodologies should reflect sex differences across critical metrics of adaptation to training. Surrogate markers of ...

DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...

Following a disappointing performance from the company’s CAR-T candidate in an early-stage cancer trial, BioNTech is winding down cell therapy manufacturing at its inaugural U.S. plant.

More information: Jeremias Motte et al, CD19-targeted CAR T-cell therapy for treatment-refractory autoimmune neuropathies, The Lancet Neurology (2025). DOI: 10.1016/S1474-4422 (25)00199-1 ...

CAR T-cell therapy as option for diseases of the peripheral nervous system Our work shows that the targeted use of CAR T-cells is possible and of significant clinical benefit, even for severe ...

Press Release Celltrio®, a pioneering life sciences company delivering advanced automation solutions for cell culturing and cell & gene therapy, today announced the closing of a $15 million ...

Johnson & Johnson said the first clinical data from its ongoing Phase 1b study of JNJ-4496, a chimeric antigen receptor T-cell therapy, shows encouraging potential in treating large B-cell ...

Those with sickle cell disease in the United States can have a shortened lifespan into their 50s, and even shorter in other countries. Roughly 100,000 Americans currently suffer from sickle cell ...

Send a tip to our reporters Site feedback: Take our Survey By Ashleigh Furlong June 11, 2025 at 4:22 AM EDT ...